
    
      The immune response to COVID-19 vaccination will be assessed at the following time points:

      T0: the day of vaccination T1: the day of the booster dose according to the schedule of the
      two vaccines (Pfizer/BioNTech or Moderna) T2: between 5 and 7 weeks after T0 for those
      vaccinated with Pfizer/BioNTech and between 6 and 8 weeks after T0 for those vaccinated with
      Moderna.

        -  T3: 12 (± 1) weeks after T0

        -  T4: 24 (± 2) weeks from T0

        -  T5: 52 (± 2) weeks from T0 Prevention of SARS-CoV-2 infection will be assessed in terms
           of incidence of SARS-CoV-2 infections (NF molecular swab positive), and of SARS-CoV-2
           infections requiring hospitalisation.
    
  